Loading...
You are here:  Home  >  Health  >  Current News

Pfizer immuno-oncology drug wins U.S. approval for bladder cancer



(Reuters) - U.S. health regulators on Tuesday granted accelerated approval for Pfizer Inc's immuno-oncology drug Bavencio to treat advanced bladder cancer, marking the second approval in less than two months for the treatment developed along with Germany's Merck KGaA.


Other News

Brazil and Colombia to scale up bacterial fight against Zika and dengue LONDON (Reuters) - Health authorities in Colombia and Brazil will launch large-scale mosquito-control campaigns using a using naturally occurring ba...
Imperial Brands could launch heated tobacco product in months if needed LONDON (Reuters) - Britain's Imperial Brands, the fourth-largest international tobacco company, remains committed to its pursuit of e-cigarettes as ...
Trump’s push to replace Obamacare faces trouble as U.S. Congress returns WASHINGTON (Reuters) - President Donald Trump's effort to roll back Obamacare faced growing obstacles on Monday as Republicans who control the U.S. ...

Found news:

Loading...

You might also like...

Study of e-cigarettes in UK teenagers gives mixed signals

Read More →